Unease Grows Among U.S. Doctors Over Indian Drug Quality

WASHINGTON/NEW YORK (Reuters) - Some U.S. doctors are becoming concerned about the quality of generic drugs supplied by Indian manufacturers following a flurry of recalls and import bans by the Food and Drug Administration.

India supplies about 40% of generic and over-the-counter drugs used in the United States, making it the second-biggest supplier after Canada.

In recent months, the FDA, citing quality control problems ranging from data manipulation to sanitation, has banned the importation of products from Ranbaxy Laboratories Ltd, Wockhardt Ltd and, most recently, Sun Pharmaceutical Industries Ltd.

"I'm just beginning to realize the gravity of the problem," said Dr. Steven Nissen, head of cardiology at the Cleveland Clinic. "It's terrible and it is starting to get a lot of traction among physicians."

For full article please follow link...

Source:
Tanveer Hussain MS, RPhI

Clinical Pharmacist @ VA HVHCS, Castle Point, NY
Chairman, Pakistani American Pharmacists Association, NY, USA

Reference: http://in.reuters.com/article/2014/03/18/usa-india-genericdrugs-idINDEEA2H03120140318 ,  

By Toni Clarke and Bill Berkrot, March 19, 2014 Editors' Recommendations, Reuters Health Information

Browse More Articles

Tweet

Written by Unknown

OpenDoor aims to provide Health Awareness. l OpenDoor is a platform used to Learn and Coach.